[Form 4] BeOne Medicines Ltd. American Insider Trading Activity

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

4

Rhea-AI Filing Summary

Analyzing...

07/22/2025 - 04:54 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Beigene Ltd

NASDAQ:ONC

ONC Rankings

#591 Ranked by Market Cap

N/A Ranked by Dividends

ONC Latest News

Jul 16, 2025

BeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6

Jul 10, 2025

European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma

Jun 26, 2025

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

Jun 25, 2025

BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®

Jun 12, 2025

BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025

ONC Latest SEC Filings

Jul 18, 2025

[144] BeOne Medicines Ltd. American SEC Filing

Jul 11, 2025

[Form 4] BeOne Medicines Ltd. American Insider Trading Activity

Jul 9, 2025

[144] BeOne Medicines Ltd. American SEC Filing

Jul 8, 2025

[144] BeOne Medicines Ltd. American SEC Filing

Jun 25, 2025

[Form 4] BeOne Medicines Ltd. American Insider Trading Activity

ONC Stock Data

Market Cap 29.19B

Float 88.96M

Insiders Ownership 19.24%

Institutions Ownership 42.54%

Short Percent 2.36%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country Cayman Islands

City GRAND CAYMAN